Correction Volume 15, Issue 12 pp 5951—5953
Correction for: Efficacy and safety of recombinant human follicle-stimulating hormone in patients undergoing in vitro fertilization-embryo transfer
- 1 The First Affiliated Hospital of Zhengzhou University, Reproductive Medicine, Zhengzhou, China
- 2 Sir Run Run Shaw Hospital of Zhejiang University, Reproductive Medicine, Hangzhou, China
- 3 Southern Medical University, Reproductive Medicine, Guangzhou, China
- 4 Second Affiliated Hospital of Wenzhou Medical University, Reproductive Medicine, Wenzhou, China
- 5 Peking University Shenzhen Hospital, Reproductive Medicine, Shenzhen, China
- 6 Hainan Medical College, Reproductive Medicine, Haikou, China
Received: March 27, 2023 Accepted: June 20, 2023 Published: June 29, 2023
https://doi.org/10.18632/aging.204490How to Cite
Correction for:
Aging (Albany NY). 2020;
12:4918-4930
.
https://doi.org/10.18632/aging.102919
PMID: 32209728
Copyright: © 2023 Hu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.